TELADOC HEALTH, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
TELADOC HEALTH, INC. (TDOC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $3.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-30
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.50M, a 20.64% decline year-over-year.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.90M, a 17.66% decline year-over-year.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $4.38M, a 103.77% increase year-over-year.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $3.78M, a 68.73% increase year-over-year.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $12.36M, a 32.93% increase from fiscal 2024.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $9.29M, a 20.21% decline from fiscal 2023.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $11.65M, a 0.91% decline from fiscal 2022.
- TELADOC HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $11.76M, a 2.42% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.39M 10-Q · filed 2026-07-30 | $7.78M derived: sum of 3 quarters · filed 2026-07-30 | $11.56M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-04-30 | $6.28M derived: sum of 2 quarters · filed 2026-04-30 | $10.06M derived: sum of 3 quarters · filed 2026-04-30 | $11.95M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.17M derived: sum of 2 quarters · filed 2026-02-26 | $10.05M derived: sum of 3 quarters · filed 2026-07-30 | $12.36M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.67M derived: sum of 2 quarters · filed 2026-07-30 | $7.97M 10-Q · filed 2025-10-30 | $10.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.19M 10-Q · filed 2026-07-30 | $6.34M derived: sum of 3 quarters · filed 2026-07-30 | $8.58M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $2.31M 10-Q · filed 2026-04-30 | $4.46M derived: sum of 2 quarters · filed 2026-04-30 | $6.70M derived: sum of 3 quarters · filed 2026-04-30 | $8.99M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.39M derived: sum of 2 quarters · filed 2026-02-26 | $6.68M derived: sum of 3 quarters · filed 2026-02-26 | $9.29M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.53M derived: sum of 2 quarters · filed 2025-10-30 | $7.14M 10-Q · filed 2025-10-30 | $10.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $4.90M 10-Q · filed 2025-07-30 | $8.23M derived: sum of 3 quarters · filed 2026-02-26 | $10.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.61M 10-Q · filed 2025-05-01 | $5.94M derived: sum of 2 quarters · filed 2026-02-26 | $8.49M derived: sum of 3 quarters · filed 2026-02-26 | $11.21M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.87M derived: sum of 2 quarters · filed 2026-02-26 | $8.59M derived: sum of 3 quarters · filed 2026-02-26 | $11.65M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $5.27M derived: sum of 2 quarters · filed 2024-10-31 | $8.32M 10-Q · filed 2024-10-31 | $10.82M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.78M 10-Q · filed 2024-08-01 | $8.27M derived: sum of 3 quarters · filed 2025-02-27 | $10.99M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.06M 10-Q · filed 2024-04-26 | $5.55M derived: sum of 2 quarters · filed 2025-02-27 | $8.27M derived: sum of 3 quarters · filed 2025-02-27 | $11.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.22M derived: sum of 2 quarters · filed 2025-02-27 | $8.58M derived: sum of 3 quarters · filed 2025-02-27 | $11.76M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $6.09M derived: sum of 2 quarters · filed 2023-10-27 | $9.27M 10-Q · filed 2023-10-27 | $13.13M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $6.54M 10-Q · filed 2023-07-28 | $10.40M derived: sum of 3 quarters · filed 2024-02-23 | $12.73M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $3.17M 10-Q · filed 2023-05-02 | $7.04M derived: sum of 2 quarters · filed 2024-02-23 | $9.36M derived: sum of 3 quarters · filed 2024-02-23 | $12.27M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $6.19M derived: sum of 2 quarters · filed 2024-02-23 | $9.10M derived: sum of 3 quarters · filed 2024-02-23 | $12.05M 10-K · filed 2024-02-23 |
| 2021-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $5.24M derived: sum of 2 quarters · filed 2022-11-02 | $8.19M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $5.86M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $2.95M 10-Q · filed 2021-05-03 | |||
| 2020-12-31 | $6.89M 10-K · filed 2021-03-01 | |||
| 2020-03-31 | $1.52M 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | $6.00M 10-K · filed 2021-03-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |